Jyothy Labs
Jyothy Labs Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Jyothy Labs Limited, framed against the sector median so the premium or discount is obvious at a glance.
Jyothy Labs Limited trades at a P/E of 21.84× and P/B of 4.58×, against the Fast Moving Consumer Goods sector median P/E of 34.10×.
Valuation
Profitability
Growth
Financial Health
Jyothy Labs Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Jyothy Labs Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Jyothy Labs Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Jyothy Labs Limited, switchable between annual and quarterly views, consolidated or standalone.
Jyothy Labs Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹7,426.91 Cr and reported EPS of ₹9.06.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,764 | 1,814 | 1,711 | 1,909 | 2,196 | 2,486 | 2,757 | 2,847 |
| Other Income | 49 | 28 | 20 | 18 | 19 | 40 | 54 | 56 |
| Total Income | 1,813 | 1,841 | 1,731 | 1,928 | 2,215 | 2,526 | 2,811 | 2,903 |
| Cost of Goods Sold (COGS) | 875 | 971 | 901 | 1,010 | 1,283 | 1,435 | 1,404 | 1,420 |
| Gross Profit | 888 | 843 | 810 | 899 | 914 | 1,051 | 1,353 | 1,427 |
| +Operating Expenses | 618 | 562 | 559 | 584 | 665 | 735 | 873 | 928 |
| EBITDA | 271 | 281 | 251 | 315 | 248 | 316 | 480 | 500 |
| +Non-Operating Expenses | 79 | 66 | 82 | 51 | 70 | 70 | 55 | 58 |
| Profit Before Tax (PBT) | 241 | 243 | 182 | 235 | 197 | 299 | 479 | 489 |
| +Tax Expense | 62 | 45 | 19 | 44 | 38 | 59 | 110 | 118 |
| Total Profit for Period | 179 | 198 | 163 | 191 | 159 | 240 | 369 | 370 |
| Less: Non-controlling Interests | -7 | -7 | -8 | -9 | -3 | -0 | -0 | -0 |
| Net Profit (Owner's PAT) | 186 | 205 | 170 | 199 | 162 | 240 | 369 | 371 |
| Earnings Per Share (EPS) | 5.12 | 5.59 | 4.64 | 5.43 | 4.41 | 6.53 | 10.03 | 10.09 |
| Diluted Shares Outstanding (Nos.) | 36 | 37 | 37 | 37 | 37 | 37 | 37 | 37 |
| +Additional Disclosures | 2,441 | 2,560 | 2,437 | 2,672 | 3,298 | 3,668 | 3,735 | 3,828 |
| Sales Growth % | — | 2.83 | -5.65 | 11.57 | 15.05 | 13.18 | 10.90 | 3.27 |
| YoY Sales Growth % | — | 2.83 | -5.65 | 11.57 | 15.05 | 13.18 | 10.90 | 3.27 |
| Material Cost % | 32 | 39 | 41 | 42 | 50 | 52 | 45 | 48 |
| Employee Cost % | 11 | 11 | 13 | 12 | 11 | 11 | 11 | 11 |
| Other Cost % | 24 | 20 | 20 | 18 | 19 | 19 | 21 | 21 |
| OPM % | 15 | 15 | 15 | 16 | 11 | 13 | 17 | 18 |
| Tax % | 26 | 19 | 10 | 19 | 19 | 20 | 23 | 24 |
| Profit Growth % | — | 10.22 | -16.98 | 17.13 | -18.78 | 48.01 | 54.11 | 0.29 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 240 | 251 | 198 | 259 | 190 | 266 | 430 | 443 |
Jyothy Labs segment analysis: revenue and profit mix.
Disclosed business segments at Jyothy Labs with their share of revenue and profit, switchable between consolidated and standalone reporting.
Jyothy Labs discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Jyothy Labs Limited investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Jyothy Labs Limited, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Jyothy Labs Limited's investment case rests on 7 positive markers and 7 flagged concerns drawn from the latest reported filings.
What you're getting.
Jyothy Labs demonstrates robust profitability with a strong Return on Equity (ROE) of 19.00% and Return on Capital Employed (ROCE) of 24.60%. This indicates efficient capital use and healthy returns for shareholders, supported by a solid 17.60% operating profit margin.
The company shows consistent growth, with quarterly sales increasing by 1.06% and quarterly profit rising by 1.55%. This positive trend suggests healthy demand for its products and effective operational management, reflecting a stable business trajectory.
Jyothy Labs maintains a significant promoter holding of 62.9%, signaling strong management confidence and commitment. This high stake reduces the risk of hostile takeovers, providing stability and a positive indicator for long-term investors.
The company exhibits a robust financial structure with a very low debt-to-equity ratio of 0.03. This indicates minimal financial leverage and a strong balance sheet, significantly reducing financial distress risk and boosting investor confidence.
The FMCG sector, where Jyothy Labs operates, generally benefits from increasing consumer spending and population growth. This broad market expansion offers a significant opportunity for sustained revenue growth and market share gains.
What can break it.
Jyothy Labs' Price-to-Earnings (P/E) ratio stands at 32.20, which is relatively high. This valuation metric suggests the stock might be overvalued compared to its current earnings, warranting careful consideration by potential investors.
While quarterly profits show growth, the absolute net profit of INR 76.00 crore in the latest quarter remains modest. This figure needs careful assessment against the company's market capitalization and its long-term growth potential.
The stock has shown significant volatility, with a 52-week high of INR 535.00 and a low of INR 268.00. This wide price fluctuation presents a notable risk for investors prioritizing stability and consistent returns in their portfolio.
Despite high promoter holding, the public shareholding is relatively low at 8.91%. This limited float could potentially restrict liquidity, making it challenging for investors to execute large trades quickly and potentially impacting stock price stability.
The Fast Moving Consumer Goods (FMCG) sector is highly competitive, with numerous established players and new entrants. Intense competition could pressure Jyothy Labs' market share and profit margins, impacting its long-term growth prospects.
What would change my mind.
Trim if P/E re-rates above 28 (~0.8× the sector multiple of 34.1). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 3.75. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 17%. The operating engine is no longer compounding capital efficiently.
Jyothy Labs Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Jyothy Labs Limited is highlighted for quick read-across.
Quick Compare
Jyothy Labs Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Jyothy Labs Limited — derived from the live tape, not yesterday's close.
Jyothy Labs Limited last traded at ₹202.71 with an intraday range of ₹201.67–₹206 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹202.71| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 213.91 | +11.20 | +5.53% |
| R3 | 209.58 | +6.87 | +3.39% |
| R2 | 207.79 | +5.08 | +2.51% |
| R1 | 205.25 | +2.54 | +1.25% |
| PIVOT | 203.46 | 0.75 | 0.37% |
| CURRENT | 202.71 | — | — |
| S1 | 192.26 | -10.45 | -5.16% |
| S2 | 196.59 | -6.12 | -3.02% |
| S3 | 199.13 | -3.58 | -1.77% |
| S4 | 200.92 | -1.79 | -0.88% |
JYOTHYLAB is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 203.54 ~ 206
Trading Below opening range, showing Bearishness
Jyothy Labs Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Jyothy Labs Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Jyothy Labs Limited stood at 55.3% of traded volume, against a 20-day average of 52.3%.
Jyothy Labs announcements: results, concalls, ratings, M&A.
Filings Jyothy Labs sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Jyothy Labs files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 164 documents below.
General Updates
Jyothy Labs Limited has informed the Exchange about General Updates- Letter to shareholders for web-link of Annual Report 2025-26
Copy of Newspaper Publication
Jyothy Labs Limited has informed the Exchange about Copy of Newspaper Publication
Updates
Jyothy Labs Limited has informed the Exchange regarding 'Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India…
Updates
Jyothy Labs Limited has informed the Exchange regarding 'Notice convening 35th Annual General Meeting of the Company forthe Financial Year 2025-26'.
Copy of Newspaper Publication
Jyothy Labs Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Jyothy Labs insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Jyothy Labs as reported to SEBI — buying and selling signals from the people who know the business best.
Jyothy Labs insider activity below tracks 4 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| M R Jyothy | Insider | 29 Mar 2025 | buy | +8.24 L | — | — |
| M. P. Ramachandran | Insider | 29 Mar 2025 | sell | −8.24 L | — | — |
| M. P. Ramachandran | Insider | 27 Jan 2025 | sell | −13.64 Cr | — | — |
| M. G. Shanthakumari | Insider | 27 Jan 2025 | buy | +13.64 Cr | — | — |
Jyothy Labs dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Jyothy Labs has declared, sequenced by announce and record date.
Jyothy Labs corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Jyothy Labs Limited: business, sector, key facts.
What Jyothy Labs Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Jyothy Labs Limited operates in the Fast Moving Consumer Goods, listed as NSE: JYOTHYLAB, BSE: 532926.
Jyothy Labs Limited is a prominent Indian company specializing in the manufacturing and marketing of a diverse range of fast-moving consumer goods (FMCG). Their product portfolio caters to various household needs, encompassing fabric care, dishwashing solutions, personal care items, and household insecticides. The company's strong market presence stems from its successful operation across multiple segments, each contributing significantly to its overall revenue.
The Dishwashing segment is a significant contributor, offering a comprehensive selection of products under the well-known Pril and Exo brands. This includes dishwashing bars, gels, liquids, powders, and even specialized scrubbing tools, catering to diverse consumer preferences and cleaning needs. Their strength in this area positions them as a major player in the Indian dishwashing market.
In the Fabric Care segment, Jyothy Labs offers a broad array of products aimed at enhancing laundry and fabric care. This segment houses popular brands like Henko, Mr. White, Ujala, and More light, featuring products such as fabric whiteners, enhancers, detergent powders, and liquids. This diverse range caters to a wide consumer base with varying laundry needs and preferences.
The Household Insecticides segment focuses on providing effective pest control solutions for homes. This includes a variety of products under the Maya, T-Shine, and Maxo brands, covering mosquito repellents (coils, liquids, and sticks), surface cleaners, and air care products. This segment highlights Jyothy Labs' commitment to providing solutions for household hygiene.
The Personal Care segment contributes to the company's holistic approach to consumer needs, providing a range of products under the Margo, Fa, and Neem Active brands. This includes body soaps, toothpastes, deodorants, talcum powders, aftershave products, and hand washes. The diversity in this range showcases Jyothy Labs' strategic expansion into personal care product categories.
Finally, the Others segment encompasses a variety of additional offerings, including incense sticks (Maya brand), toilet and floor cleaners, and even dry cleaning and laundry services under the Fabric Spa brand. This demonstrates Jyothy Labs’ commitment to expanding its services and offerings beyond its core product lines, showcasing diversification strategies. The company's foundation in 1983, based in Mumbai, India, reflects a long history of successful operation in the competitive FMCG market.
Questions investors ask about Jyothy Labs Limited (JYOTHYLAB).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Jyothy Labs Limited (JYOTHYLAB)?
The current share price of Jyothy Labs Limited (JYOTHYLAB) is ₹202.71. Today, the stock has declined by ₹1.83 (0.89%), trading in a range of ₹201.67 to ₹206. The stock opened at ₹205.49 with a trading volume of 6,51,944 shares.
02Is Jyothy Labs Limited stock a good investment for long-term?
Jyothy Labs Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹7,426.91 crores, P/E ratio of 21.84, ROE of 22.43%, and ROCE of 24.60%. The dividend yield stands at 1.73%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Jyothy Labs Limited stock?
The 52-week high price of Jyothy Labs Limited (JYOTHYLAB) is ₹364.8, while the 52-week low is ₹196.15. Currently trading at ₹202.71, the stock is 3.9% away from its 52-week low and 44.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Jyothy Labs Limited stock at the current price?
Whether to buy Jyothy Labs Limited stock at ₹202.71 depends on multiple factors. The stock is currently trading with a P/E ratio of 21.84 and P/B ratio of 4.58. Today's performance shows a loss of 0.89%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Jyothy Labs Limited and when is the next dividend?
Jyothy Labs Limited offers a dividend yield of 1.73%, which means for every ₹100 invested at the current price of ₹202.71, you can expect to receive approximately ₹1.73 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Jyothy Labs Limited?
Jyothy Labs Limited's key financial metrics include: P/E Ratio: 21.84, P/B Ratio: 4.58, ROE: 22.43%, ROCE: 24.60%, Dividend Yield: 1.73%, EPS: ₹9.06, Book Value: ₹43.26, and Debt-to-Equity: 3.25. The company's market cap stands at ₹7,426.91 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Jyothy Labs Limited stock performing today in the market?
Jyothy Labs Limited stock opened at ₹205.49 and is currently trading at ₹202.71, showing a decline of ₹1.83 (0.89%). The intraday high is ₹206 and low is ₹201.67. The trading volume stands at 6,51,944 shares, indicating moderate market participation today.
08What is the P/E ratio of Jyothy Labs Limited and what does it indicate?
Jyothy Labs Limited has a Price-to-Earnings (P/E) ratio of 21.84, which means investors are willing to pay ₹21.84 for every ₹1 of earnings. With an EPS of ₹9.06, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Jyothy Labs Limited (JYOTHYLAB) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Ambica Agarbathies & Aroma industries (AMBICAAGAR) Share PricePeer
- Eveready Industries India (EVEREADY) Share PricePeer
- Indo-National (NIPPOBATRY) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- All Technical ScreenersScreener
- All Trading StrategiesStrategy